Clinical Trials
2 trialsNCT02605083 2020-11-02
A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors
Effector Therapeutics
Phase 1/2 Terminated
NCT02937675 2020-11-02
A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies
Effector Therapeutics
Phase 1/2 Terminated